TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

TIGIT Can Exert Immunosuppressive Effects on CD8+ T Cells by the CD155/TIGIT Signaling Pathway for Hepatocellular Carcinoma In Vitro

Published:2020-08-14 Issue:8 Volume:43 Page:236-243
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Zhang Changkun,Wang Yang,Xun Xiaodong,Wang Siqi,Xiang Xiao,Hu Shihua,Cheng Qian,Guo Jinghang,Li Zhao,Zhu Jiye

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference42 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009;Poon;Lancet Oncol,2009

3. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017

4. Elements of cancer immunity and the cancer-immune set point;Chen;Nature,2017

5. Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy;Kean;Immunol Rev,2017

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between TIGIT expression on T cells and the prognosis of patients with hepatocellular carcinoma;BMC Cancer;2024-09-09

2. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma;Translational Oncology;2024-07

3. Molecular insight into T cell exhaustion in hepatocellular carcinoma;Pharmacological Research;2024-05

4. CD155-TIGIT Axis as a Therapeutic Target for Cancer Immunotherapy;Current Medicinal Chemistry;2024-04

5. CD155 as an emerging target in tumor immunotherapy;International Immunopharmacology;2024-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3